Golub Capital Provides One-Loan Debt Facility to Support the Acquisition of Evolution Research Group by Linden Capital Partners

Press Release
June 15, 2018

CHICAGO, June 15, 2018 — Golub Capital recently announced that, as Administrative Agent, Sole Lead Arranger and Sole Bookrunner, it provided a GOLD facility to support the acquisition of Evolution Research Group (“ERG”) by Linden Capital Partners. GOLD financings are Golub Capital One-Loan Debt facilities.

ERG is the largest independent clinical research site organization in the U.S., focused on developing neuroscience drugs. The company is a leader in early phase and specialized population clinical studies for central nervous system conditions including neurological disorders, chronic pain, addictions and acute and post-op pain. Clinical trials are a critical part of the medical research and drug development process, as they allow scientists to test the safety and effectiveness of new drugs on humans.

“The Golub Capital healthcare finance team provided us with certainty from the outset and delivered an efficient solution, consistent with our past experiences with them,” said Michael Farah, partner at Linden Capital Partners. “We look forward to continuing to work with Golub Capital on this deal and others to come.”

“ERG’s sustainable business model and vital importance in the healthcare and pharmaceutical industries led us to believe this was a strong partnership opportunity,” said Stefano Robertson, head of Healthcare Finance and managing director at Golub Capital. “We are pleased to have facilitated this transaction for Linden Capital Partners, a long-term partner of the firm.”

About Golub Capital Middle Market Lending
Golub Capital’s Middle Market Lending group provides financing for middle market, private equity-backed transactions with hold positions of over $600 million and is an arranger of credit facilities up to $1 billion. Golub Capital’s award-winning team strives to establish long-term, win-win partnerships by providing dependable, fast and creative solutions that meet private equity sponsors’ and portfolio companies’ needs.

Golub Capital is a nationally recognized credit asset manager with over $25 billion of capital under management. For over 20 years, Golub Capital has provided credit to help medium-sized U.S. businesses grow. The firm’s award-winning Middle Market Lending business provides financing for middle market companies and their private equity sponsors. Golub Capital’s credit expertise also forms the foundation of its Late Stage Lending and Broadly Syndicated Loan businesses. Golub Capital has worked hard to build a reputation as a fast, reliable provider of compelling financing solutions, and we believe this has inspired repeat clients and investors. Today, the firm has over 350 employees with lending offices in Chicago, New York and San Francisco. For more information, please visit golubcapital.com.

About Evolution Research Group, LLC
Evolution Research Group, LLC is comprised of ten wholly-owned and operated clinical research sites, Thievon-Wright Consulting Group, and an established network of 11 affiliated clinical research sites. ERG conducts a wide range of trials in specialized populations including those suffering from psychiatric and neurological disorders, sleep disorders, addictions, acute and chronic pain, renal insufficiency and hepatic impairment, as well as normal healthy volunteers. For more information, please visit www.evolutionresearchgroup.com.

About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare industry. Linden’s strategy is based upon three elements: i) healthcare specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. For more information, please visit www.lindenllc.com.